title: Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders.
authors.forename: Hideo
authors.initials: H
authors.lastname: Hashizume
authors.forename: Izumi
authors.initials: I
authors.lastname: Uchiyama
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Kawamura
authors.forename: Takafumi
authors.initials: T
authors.lastname: Suda
authors.forename: Masahiro
authors.initials: M
authors.lastname: Takigawa
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Tokura
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000139:chemically induced / Q000150:complications*; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D019226:Oral Ulcer / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D017285:Polymyositis / Q000188:drug therapy
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate